| 000 | 00786 a2200253 4500 | ||
|---|---|---|---|
| 005 | 20250512003242.0 | ||
| 264 | 0 | _c19910430 | |
| 008 | 199104s 0 0 eng d | ||
| 022 | _a0092-6019 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLacerna, L V | |
| 245 | 0 | 0 |
_aActivated killer monocytes: use in clinical trials. _h[electronic resource] |
| 260 |
_bImmunology series _c1989 |
||
| 300 |
_a127-38 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article | ||
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImmunotherapy, Adoptive |
| 650 | 0 | 4 |
_aKiller Cells, Natural _ximmunology |
| 650 | 0 | 4 |
_aMonocytes _ximmunology |
| 650 | 0 | 4 |
_aNeoplasms _xtherapy |
| 700 | 1 | _aSugarbaker, P H | |
| 700 | 1 | _aStevenson, H C | |
| 773 | 0 |
_tImmunology series _gvol. 48 _gp. 127-38 |
|
| 999 |
_c2494316 _d2494316 |
||